(Q34240991)

31 July 2017

1 reference

title

Citalopram: a comprehensive review (English)

1 reference

31 July 2017

Pollock BG

1

1 reference

PubMed ID

11336616

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

681-698

1 reference

31 July 2017

4

1 reference

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram for post-stroke pathological crying

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Effect of citalopram on plasma levels of oral theophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Excretion of citalopram in breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram and breast-feeding: serum concentration and side effects in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991–1997: the favourable consequences of the increasing use of SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.681

21 January 2018

Identifiers

DOI

10.1517/14656566.2.4.681

1 reference

31 July 2017

1 reference

PubMed ID

11336616